Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $74.3M |
| Sales growthchange from the year before | +3.2% |
| Net marginshare of sales kept as profit | 175.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | 172.9% |
| Return on equityprofit vs. shareholders' accounting value | 16.1% |
| Debt / equitydebt vs. shareholders' accounting value | 0.19 |
| Change in share countnegative = the company is buying back its shares | -1.5% |
4 insiders bought $60K; 1 insider sold $650K on the open market.
| Hageboeck Charles RPresident & CEO · Director | SoldJul 30 | 4,485 shat $144.96 · $650K |
| Fisher Robert DDirector | Bought (plan)Jul 21 | 156 shat $134.55 · $21K |
| Hoyer James ADirector | Bought (plan)Jul 21 | 95 shat $134.55 · $13K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy